Loading company…
St. Louis-based medical technology company making robotic systems for cardiac interventional procedures.
Stereotaxis, Inc., founded in 1990 and headquartered in St. Louis, US, makes robotic systems that help physicians with complex cardiac procedures, particularly cardiac ablation, by improving catheter precision. It sells directly to hospitals and healthcare providers. In 2023 it generated revenue of USD 26.77 mn and EBITDA of USD -21.24 mn. The company raised a total of USD 10.00 mn in its Series A round in May 2017 and has been engaged in four deals to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in